• Company
• Technology
• Products/Development Pipeline
• Business Development
• Investor Relations
• SEC Filings
• Presentations/Events
• Analyst Reports
• Information Request
• Media & PR

Investor Information

Investor Information

Biodelivery Sciences International, Inc. is a NASDAQ-listed company. The company's common stock trades under the ticker symbols BDSI.

Current Financial Information/Stock Quote

Press Releases

• BDSI's Press Release database

Analyst Reports

• Analyst Reports on BDSI

Investor Presentations and Events

• BDSI's current investor presentations and live and archived webcasts can be accessed here.

BDSI Investor Fact Sheet

• BDSI's Investor Fact Sheet can be accessed here.

BDSI Charters

• Audit Committee Charter
• Nominating and Corporate Governance Committee Charter
• Compensation Committee Charter

BDSI Code of Ethical Conduct

• On March 24, 2003, BDSI's Board of Directors adopted a Code of Ethical Conduct for the company's principal executive and financial officers. (revision: April 2008)

BDSI Disclosure Policy

• BioDelivery Sciences International, Inc. is committed to the fair disclosure of information about the
  company consistent with the Securities and Exchange Commission's Regulation Fair Disclosure
  ("Regulation FD"). Read our Fair Disclosure Policy here.

Company Filings

• The full text of BDSI's filings with the SEC are available at the SEC's EDGAR website.
  

Information Requests

• For information on BDSI, please e-mail bdsi-info@bdsinternational.com.

Investor relations and press questions should be directed to:

Bryan Armstrong FD Ashton Partners 312-553-6707 bryan.armstrong@fdashtonpartners.com